P. Rigatti
Papers
2
Total Citations
17
H-Index
2
About
P. Rigatti is a prominent urologic oncologist whose research has significantly advanced the surgical management of genitourinary cancers. His major contributions center on the treatment of metastatic renal cell carcinoma (RCC) and the optimization of functional outcomes following radical prostatectomy. Rigatti’s landmark work demonstrated that complete metastasectomy is an independent predictor of improved cancer-specific survival in patients with clinically metastatic RCC, a finding that has shaped surgical decision-making for advanced kidney cancer (15 citations). This study provided critical evidence supporting aggressive surgical resection of metastases to prolong survival. Additionally, Rigatti has investigated factors influencing erectile function recovery after nerve-sparing radical prostatectomy, comparing open and robotic approaches to refine surgical techniques and improve patients’ quality of life. His comparative analysis of intrafascial nerve-sparing techniques has helped urologists better predict postoperative potency outcomes. Through these contributions, Rigatti has advanced both oncologic efficacy and functional preservation in urologic surgery, establishing himself as a key figure in evidence-based surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2